USPTO Examiner FANG MICHAEL YIMING - Art Unit 3798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19184495SYSTEMS AND METHODS FOR ULTRASONIC GUIDED NEEDLE INSERTIONApril 2025August 2025Allow410YesNo
18984429Needle Guidance SystemDecember 2024January 2026Allow1310NoNo
18829655ENDOSCOPE BALLOON, ENDOSCOPE BALLOON UNIT, AND ENDOSCOPESeptember 2024March 2026Allow1810YesNo
18813602INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCERAugust 2024March 2026Allow1910NoNo
18780443ULTRASONIC ENDOSCOPE AND MANUFACTURING METHOD OF ULTRASONIC ENDOSCOPEJuly 2024February 2026Allow1910YesNo
18778868ULTRASOUND DIAGNOSTIC SYSTEMJuly 2024December 2025Allow1710NoNo
18568038MINIMALLY INVASIVE HISTOTRIPSY SYSTEMS AND METHODSDecember 2023November 2025Allow2310NoNo
18359417SYSTEMS AND METHODS FOR WIRELESS LOCALIZATIONJuly 2023June 2025Allow2230NoNo
18215497INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCERJune 2023May 2024Allow1120YesNo
18144772ROLLED FLEXIBLE SUBSTRATE WITH INTEGRATED WINDOW FOR INTRALUMINAL ULTRASOUND IMAGING DEVICEMay 2023October 2025Allow2950YesNo
18188111ULTRASOUND DIAGNOSTIC APPARATUS AND OPERATION METHOD THEREOFMarch 2023May 2025Allow2620NoNo
18169836MEDICAL SYSTEMFebruary 2023February 2026Allow3610NoNo
18021096A MEDICAL APPARATUS FOR THE NON-INVASIVE TRANSMISSION OF FOCUSSED SHEAR WAVES TO IMPACT CELLULAR BEHAVIOURFebruary 2023September 2025Allow3220YesNo
18106889BODY VESSEL NAVIGATION SYSTEMFebruary 2023February 2025Abandon2510NoNo
17979315TARGET APPARATUS FOR USE IN A SURGICAL NAVIGATION SYSTEM, SURGICAL NAVIGATION SYSTEM, AND METHOD FOR PRODUCING SUCH A TARGET APPARATUSNovember 2022December 2025Abandon3711NoNo
18048780Needle Guidance SystemOctober 2022December 2024Allow2650YesNo
17901900Physiological Acquisition System For Use In An RF-Shielded RoomSeptember 2022September 2024Allow2500NoNo
17800766REAL-TIME AI FOR PHYSICAL BIOPSY MARKER DETECTIONAugust 2022June 2025Abandon3420NoNo
17797595ULTRASONIC PROBE AND MANUFACTURING METHOD THEREFORAugust 2022March 2025Allow3230YesNo
17748237DEVICES, SYSTEMS, AND METHODS FOR REDUCING SIGNAL NOISE IN ENDOSCOPIC ROTATIONAL IMAGINGMay 2022May 2024Allow2420YesNo
17725196ROBOTIC SURGERYApril 2022June 2025Abandon3820NoNo
17720764SYSTEMS AND METHODS FOR THE ASSESSMENT OF CARDIAC AMYLOIDOSISApril 2022September 2025Allow4120YesNo
17765906PARALLEL PATH PUNCTURE DEVICE GUIDEApril 2022December 2023Allow2010YesNo
17761430MULTI-SEGMENT INTRALUMINAL IMAGING DEVICE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSMarch 2022July 2025Abandon4050YesNo
17533270DUAL BRILLOUIN-PHOTOACOUSTIC MICROSCOPYNovember 2021March 2025Allow4041YesNo
176011013D LASER-ASSISTED POSITIONING SYSTEMOctober 2021April 2025Abandon4220NoNo
17310696SYSTEMS AND METHODS FOR PERFORMING MAGNETIC RESONANCE IMAGINGAugust 2021November 2024Abandon3920NoNo
17431521STATE ESTIMATION APPARATUS, STATE ESTIMATION METHOD, AND COMPUTER READABLE RECORDING MEDIUMAugust 2021March 2025Allow4320YesNo
17427044BLOOD-PRESSURE MEASUREMENT DEVICE, MODEL SETTING DEVICE, AND BLOOD-PRESSURE MEASUREMENT METHODJuly 2021May 2025Abandon4520NoNo
17298219INTERLEAVED LIGHT SOURCES AND METHODS OF THEIR USEMay 2021March 2025Abandon4620NoNo
17303295ULTRASOUND PROBE WITH ADJUSTABLE APERTUREMay 2021December 2023Allow3131YesNo
17222376METHODS AND SYSTEMS FOR AN INVASIVE DEPLOYABLE DEVICEApril 2021December 2023Abandon3220NoNo
17249873ULTRASOUND TRANSDUCER ASSEMBLY, PROBE, ENDOSCOPY SYSTEM AND MANUFACTURING METHODMarch 2021July 2024Abandon4031NoNo
17266574INTERVENTIONAL DEVICE WITH AN ULTRASOUND TRANSDUCERFebruary 2021September 2024Abandon4351YesYes
17259033Acousto-Optical Sensors for MRI Safety EvaluationJanuary 2021October 2024Abandon4511NoNo
17117731CLOSED-LOOP TOOL CONTROL FOR ORTHOPEDIC SURGICAL PROCEDURESDecember 2020January 2025Abandon4930YesNo
17101254MEDICAL IMAGE PROCESSING APPARATUSNovember 2020January 2025Allow5030YesNo
17080467Adaptive Selection of Ultrasound FrequencyOctober 2020October 2023Allow3620YesNo
17079274ULTRASOUND IMAGING METHOD AND ULTRASOUND IMAGING DEVICEOctober 2020June 2025Abandon5560YesNo
17079118IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND IMAGE PROCESSING PROGRAMOctober 2020March 2025Allow5341YesNo
17073159ULTRASOUND PROBE WITH IMPROVED THERMAL MANAGEMENTOctober 2020January 2026Allow6041NoYes
17039062DEVICES, SYSTEMS, AND METHODS FOR IMAGING WITHIN A BODY LUMENSeptember 2020January 2024Allow4051YesNo
17030026Probe ShieldSeptember 2020March 2025Allow5471YesYes
17025622MULTI-FREQUENCY MAPPING CATHETER AND METHOD OF MAPPINGSeptember 2020October 2023Allow3740YesNo
16979964BREAST ULTRASOUND WORKFLOW APPLICATIONSeptember 2020September 2024Allow4851YesNo
16964249A method for Preparing an Insertion Site for a Cannula on a Skin of a Patient, a Skin Cover Unit Therefore and Its UseJuly 2020December 2023Allow4150YesNo
16922204ENDOVASCULAR OCCLUSION DEVICE AND METHOD OF USEJuly 2020July 2024Abandon4940YesNo
16905873ULTRASONIC ENDOSCOPE AND MANUFACTURING METHOD OF ULTRASONIC ENDOSCOPEJune 2020April 2024Allow4641YesNo
16894421Pattern Interference Radiation Force (PIRF) neural stimulatorsJune 2020August 2024Allow5020NoNo
16879519DUAL LAYER ULTRASONIC TRANSDUCERMay 2020August 2024Abandon5160YesNo
16641671ABLATION CATHETER, CATHETER ARRANGEMENT AND SYSTEM FOR PROVIDING ABLATIVE TREATMENTFebruary 2020May 2024Abandon5160YesNo
16795220IDENTIFICATION OF RESPIRATORY PHASES IN A MEDICAL PROCEDUREFebruary 2020July 2024Abandon5260YesNo
16773912SYSTEMS AND METHODS FOR USING LOW INTENSITY ULTRASONIC TRANSDUCER ON THE BRAINJanuary 2020August 2025Abandon6051NoNo
16631802RF Based Monitoring Of User ActivityJanuary 2020February 2025Allow6070YesNo
16625104METHOD FOR PROCESSING ULTRASONIC IMAGEDecember 2019June 2024Abandon5440YesNo
16623974ASSEMBLY FOR IMAGING AND/OR TREATING BRAIN TISSUEDecember 2019May 2024Allow5350NoNo
16662595INTRALUMINAL ULTRASOUND NAVIGATION GUIDANCE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSOctober 2019October 2024Allow6070YesNo
16565219Ultrasound Transducer Array Architecture And Method of ManufactureSeptember 2019June 2024Allow5750YesYes
16491110IMAGING ASSEMBLY FOR INTRALUMINAL IMAGINGSeptember 2019December 2025Allow6060YesYes
16477060STRETCHABLE ULTRASONIC TRANSDUCER DEVICESJuly 2019March 2025Allow6071YesNo
16475675LOCALIZED MAGNETIC FIELD GENERATORJuly 2019January 2025Allow6061YesNo
16369783MEDICAL DIAGNOSIS APPARATUS, MEDICAL IMAGE PROCESSING APPARATUS, AND IMAGE PROCESSING METHODMarch 2019February 2024Abandon5970NoNo
16336544ELECTRICAL GROUNDING FOR IMAGING ASSEMBLY AND ASSOCIATED INTRALUMINAL DEVICES, SYSTEMS, AND METHODSMarch 2019December 2023Allow5760YesNo
16267833SURGICAL ROBOT PLATFORMFebruary 2019May 2024Abandon6040NoNo
16266442System and Method for a Wearable Vital Signs MonitorFebruary 2019January 2024Allow6030NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FANG, MICHAEL YIMING.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
0
(0.0%)
Examiner Reversed
2
(100.0%)
Reversal Percentile
99.9%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
6
Allowed After Appeal Filing
2
(33.3%)
Not Allowed After Appeal Filing
4
(66.7%)
Filing Benefit Percentile
55.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner FANG, MICHAEL YIMING - Prosecution Strategy Guide

Executive Summary

Examiner FANG, MICHAEL YIMING works in Art Unit 3798 and has examined 41 patent applications in our dataset. With an allowance rate of 56.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 50 months.

Allowance Patterns

Examiner FANG, MICHAEL YIMING's allowance rate of 56.1% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by FANG, MICHAEL YIMING receive 4.29 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by FANG, MICHAEL YIMING is 50 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +41.8% benefit to allowance rate for applications examined by FANG, MICHAEL YIMING. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 11.2% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 19.5% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.